Articles related to LEUKEMIA

Uncover the potential of nivolumab and axicabtagene ciloleucel as they showcase promising results in the latest lymphoma trials, potentially reshaping the standard of care for these malignancies.

Explore the CML SUN study’s findings, which highlight the unmet need for shared decision-making in the choice of CML treatment—a void that may have an impact on patient satisfaction and treatment outcomes.

Gain insight into how a shift in cellular environment and UV radiation exposure can instigate additional mutations, deepening our understanding of the evolution and development of rare and complex malignancies such as BPDCN.

Discover the potential of pirtobrutinib, a noncovalent BTK inhibitor, in transforming the management of refractory B-cell cancers. Explore the promising results from the recent phase 1-2 trial.

This study demonstrates how pharmacists can improve patient safety and dramatically save costs in the management of chronic myeloid leukemia by highlighting the possibility of pharmacist-led TKI cessation programs.

Discover how a groundbreaking trial using a new CRISPR gene-editing technique has successfully treated a patient with T-cell leukemia, a form of the disease resistant to conventional treatments. Learn how this innovative approach could revolutionize the treatment of various diseases affecting the blood, bone marrow, and immune systems.